Home
Conditions
Multiple Sclerosis

Clinical trial condition

Multiple Sclerosis

Explore clinical trials studying Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

2,362 public trials 355 recruiting studies

Refine in advanced search Browse all conditions

Multiple Sclerosis trial results

Completed

Metabolic Effects of a Green Tea Extract in Multiple Sclerosis Patients

NCT01417312

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Franz-Volhard Clinical Research Center at the Experimental and Clinical Research Center, Charité University Medicine Berlin and Max Delbrueck Center for Molecular Medicine Berlin, Germany

View Trial Details

Completed

Repetitive Deep Transcranial Magnetic Stimulation in Multiple Sclerosis

NCT01106365

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +10 more
Locations: Charite University Berlin (NeuroCure Clinical Research Center NCRC) Berlin, Germany

View Trial Details

Completed

Visual Reconstitution Therapy After Optic Neuritis

NCT01274702

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +8 more
Locations: NeuroCure Clinical Reserach Center, Charité Universitaetsmedizin Berlin, Germany

View Trial Details

Completed

Sunphenon in Progressive Forms of Multiple Sclerosis

NCT00799890

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Charité Universitätsmedizin Berlin (NeuroCure Clinical Research Center) Berlin, Germany

View Trial Details

Completed

Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis Patients

NCT02623946

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Clinique Neuro-Outaouais Gatineau, Quebec, Canada

View Trial Details

Completed

The Gut Microbiome in Adult Multiple Sclerosis

NCT04929145

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Universitair Ziekenhuis Brussel Jette, Brussel-Hoofdstedelijk-Gewest, Belgium

Nationaal Multiple Sclerose Centrum Melsbroek Melsbroek, Vlaams-Brabant, Belgium

View Trial Details

Completed

Functional Disorders of the Musculoskeletal System in People With Multiple Sclerosis

NCT04973501

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +7 more
Locations: Not specified

View Trial Details

Completed

The Effect of Self-Acupressure Application on Functional Composite and Quality of Life in Multiple Sclerosis Patients

NCT04936555

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: Istanbul Sabahattin Zain Universitiy Istanbul, State, Turkey (Türkiye)

View Trial Details

Completed

Safety of Switching From Rituximab to Ocrelizumab in MS Patients

NCT02980042

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

View Trial Details

Completed

Phase IIa Study of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis

NCT02738775

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations: TG Therapeutics Investigational Trial Site Phoenix, Arizona, United States

TG Therapeutics Investigational Trial Site Pasadena, California, United States

TG Therapeutics Investigational Trial Site Torrance, California, United States

TG Therapeutics Investigational Trial Site Aurora, Colorado, United States

View Trial Details

Multiple Sclerosis

Multiple Sclerosis trial results

Related conditions